Posted: March 18, 2015 at 1:40 pm
WSCS 2014: STEM CELLS AND MENTAL HEALTH
Moderator - George Perry, PhD, The University of Texas at San Antonio Speakers - Daniel J. Lodge, PhD, University of Texas Health Science Center Evan Y. Snyder, MD, PhD, FAAP, ...
By: worldstemcell
Continue reading here:
WSCS 2014: STEM CELLS AND MENTAL HEALTH - Video
Posted: March 18, 2015 at 1:40 pm
Tabadol Talk: Start-ups, stem cells STEM education
A discussion with Dr. Rana Dajani Dr. Shima Barakat http://www.facebook.com/cambridge.tabadol http://www.camtabadol.org.
By: Tabadol Cambridge
More:
Tabadol Talk: Start-ups, stem cells & STEM education - Video
Posted: March 18, 2015 at 1:40 pm
Patient Testimonial 24
By: Plexus Neuro and Stem Cell Research Centre
More here:
Patient Testimonial 24 - Video
Posted: March 18, 2015 at 1:40 pm
Cody #39;s N.G.O. Presentation - Stem Cell Research
By: Vahock126
Read this article:
Cody's N.G.O. Presentation - Stem Cell Research - Video
Posted: March 18, 2015 at 3:01 am
Charles Limoli will lead effort to see how cosmic radiation affects astronauts' cognition
Irvine, Calif., March 17, 2015 -- With $9 million in NASA funding, UC Irvine professor of radiation oncology Charles Limoli will lead a national effort to understand the early and long-term effects of space radiation on the central nervous system.
Exposure to the dangerous radiation fields in space has been shown to impair the cognitive abilities of rodents, and this data suggests that astronauts who spend extended time in space may suffer similar consequences. Limoli's team will look into the behavioral impairments of rodents attributed to space radiation exposure and the underlying causes of these deficits, including studies to quantify the structural and functional alterations to nerve cells.
This "space brain" project is part of NASA's Human Research Program, which is funding three new NASA Specialized Centers of Research on space radiation. Investigating how such radiation affects astronauts and learning ways to mitigate those effects are critical to further human exploration of space, and NASA has set its sights on exploring an asteroid and, ultimately, Mars.
Collectively, the three NSCOR teams comprise 25 investigators from 13 institutions in eight states and the District of Columbia. Limoli's group includes researchers from UCI, Loma Linda University and the Eastern Virginia Medical School. The radiation exposure studies will take place at the NASA Space Radiation Laboratory, located at the Brookhaven National Laboratory in Long Island, N.Y.
"The space environment poses unique hazards to astronauts, since a range of potential central nervous system complications can result during and after actual space travel," Limoli said. "We plan to conduct a comprehensive series of rodent studies to characterize the neurobiological mechanisms involved with radiation-induced cognitive impairment."
Results will inform efforts to minimize the effects of solar and galactic cosmic radiation on the central nervous system.
As a member of the Chao Family Comprehensive Cancer Center at UCI, Limoli studies how cranial irradiation triggers DNA damage, oxidative stress and structural alterations to neurons - issues important to not just astronauts but also patients subjected to radiotherapy for brain cancer. In addition, he has advanced preclinical research showing that stem cell treatments can limit cognitive deficits after cranial radiotherapy or systemic chemotherapy.
Fellow UCI investigators on the NASA project are Ivan Soltesz, professor and chair of anatomy & neurobiology; Munjal Acharya, assistant professor of radiation oncology; and Janet Baulch and Vipan Kumar, project scientists in Limoli's research group.
###
See the original post:
NASA awards UCI $9 million to study underlying mechanisms of 'space brain'
Posted: March 18, 2015 at 2:56 am
Dr. Atsushi Asakura is an Associate Professor of Neurology and a faculty member of the Stem Cell Institute in the University of Minnesota Medical School. He also belongs to Paul & Sheila Wellstone Muscular Dystrophy Center in the Medical School.
Dr. Asakura received his Ph.D. at the Institute of Medical Science at the University of Tokyo Graduate School and the National Institute of Neuroscience in Tokyo with Dr. Yo-ichi Nabeshima where he learned the molecular biology of skeletal muscle differentiation.
He trained at the post-doctoral level at the Fred Hutchinson Cancer Research Center in Seattle with Dr. Stephen J. Tapscott. His post-doctoral studies involved the transcription factors for skeletal muscle development during early embryogenesis.
He trained at the senior post-doctoral level at McMaster University in Hamilton and the Ottawa Health Research Institute in Ottawa with Dr. Michael A. Rudnicki where he started projects on skeletal muscle stem cells that contribute to muscle regeneration.
My laboratorys goals include attempting to understand the molecular mechanisms controlling muscle satellite cell (muscle stem cell) self-renewal and differentiation, and to develop novel therapeutic methods for Duchenne Muscular Dystrophy (DMD). This also involves the stem cell niche associated with vasculature in normal and regenerating skeletal muscle. And, we have recently begun exploration of cell based therapy with induced Pluripotent Stem Cells (iPSCs) toward muscular dystrophy model animals and heart infarction models.
See the article here:
Atsushi Asakura, Ph.D. - MED - Stem Cell Institute ...
Posted: March 18, 2015 at 2:56 am
Regulated information PRESS RELEASE
TiGenix reports its full year 2014 results
Leuven, Belgium - 17 March, 2015 - TiGenix NV (Euronext Brussels: TIG), an advanced biopharmaceutical company focused on developing and commercialising novel therapeutics from its proprietary platform of allogeneic, expanded adipose-derived stem cells, or eASC's, in inflammatory and autoimmune diseases, reported its results for 2014 today.
Business highlights
Strategic refocusing successfully completed
All resources focused on advancing the allogeneic expanded adipose-derived stem cell (eASCs) product pipeline. ChondroCelect marketing and distribution rights licensed to Sobi and Dutch manufacturing facility sold to PharmaCell
Management team strengthened with the appointment of Chief Medical Officer and VP Medical Affairs & New Product Commercialisation
Patient recruitment of Cx601 European Phase III study completed
Cx601 development for the United States progressed according to plan
Phase III trial design submitted to the Food and Drug Administration (FDA) for a Special Protocol Assessment (SPA)
Originally posted here:
TiGenix: TiGenix reports its full year 2014 results
Posted: March 18, 2015 at 2:55 am
Sophie Dillman
Sophie Dillman graduated from Boston College in December 2010 with a Bachelor of Arts in English and international studies. For the past two years, she has been the corporate editorial assistant for Voice Media Group, the largest group of metropolitan newsweeklies in the U.S. She assists the executive editor and associate managing editor.
Parkinson's disease is one of a group of neurological disorders called motor system disorders. It is a degenerative condition in which dopamine-producing...
Artificial Stem Cells May Cure Parkinson's Disease; Adult Stem Cell Findings Offer New Hope For Parkinson's Cure; More Like This. Natural Cure...
Stem cell therapy has the potential to help patients suffering from "Parkinson's disease, amyotrophic lateral sclerosis, spinal cord injury, burns, heart disease...
Stem cell research may increase understanding of cellular development and provide cell-based therapies to help cure ... Stem Cell Transplants and Parkinson's...
Lower Back Muscle Spasm Heat or Cold Treatment. ... nerve cells in the muscle signal the brain ... Some neurological disorders such...
Because stem cells are commonly derived from embryos, questions arise about how the research affects the value of human life. ... including...
Stem cells hold great promise for the treatment of many diseases and traumatic medical conditions, including Parkinson's disease, diabetes and spinal chord...
Stem Cell Research on Parkinson's Disease. Parkinson's disease is a degenerative neurological disorder that affects motor control. In Parkinson's patients, ...
Read more:
How Do Stem Cells Help Cure Parkinson's Disease? | eHow
Posted: March 18, 2015 at 2:53 am
Stem cells are fast becoming relevant to all aspects of our society, with medical, scientific, ethical, political, and economic implications. Therefore it is important that scientists and non-scientists alike be provided with accurate information about stem cell biology. The goals of the UCR Stem Cell Center is to provide the members of the community with a better understanding of the science of stem cells so that they have the necessary tools to make reasoned decisions about the related society issues.
UCR has a strong history in training undergraduate and graduate students and is developing a complete training program in stem cell biology.
Stem cell biology is currently one of the most exciting fields in science with the potential not only to answer basic biological questions but also to provide new therapies and treatments for debilitating diseases. Some of the most important biomedical breakthroughs of this century are likely to come through the use of stem cell technology.
Diseases that could in the future be treated by stem cell biology include (but are not limited to) diabetes, Parkinsons disease, spinal cord injury, Alzheimers disease, aging, heart disease, stroke, burns, amputations, and osteoarthritis.
Stem cell biology will form an important component in both the UCR Health Sciences Research Institute and future Medical School, which will work to facilitate translational research.
Web link to UCR Health Sciences Research Initiative: http://www.hsri.ucr.edu/ Web link to Medical School: http://www.medschool.ucr.edu/
Basic research is needed to understand, control, and use stem cells safely and effectively for therapeutic and environmental purposes.
The UCR Stem Cell Center is making major contributions to stem cell biology by attacking basic biological problems at an interdisciplinary level, enabling translation to the clinical level, and by using stem cells to monitor the effects of the environment on human health.
The Center has faculty working with various types of stem cells including human embryonic, mouse embryonic, hematopoietic, and human umbilical cord stem cells.
Stem cells are valuable tools that have the potential not only to treat numerous diseases, but also to study development and evaluate the toxicity of chemicals and drugs.
Go here to see the original:
Stem Cell Center - University of California, Riverside
Posted: March 18, 2015 at 2:43 am
Clinics in other countries for some time have promised dramatic results in the treatment of lung disease, primarily emphysema, through the use of autologous stem cells obtained from the patient. The stem cells are extracted from adipose (fat) tissue, treated and then injected into the patient. The cells then supposedly go to work regenerating and replacing the damaged lung tissue.
Several of this type of clinic are now popping up in parts of the United States, mostly in California and Florida. Their advertisements are filled with testimonials from patients, extolling the virtues of the treatments. The treatments are quite expensive, and would be an absolute godsend for the 30 million Americans who suffer from some stage of Chronic Obstructive Pulmonary Disease (COPD). If they worked.
Trouble is, none of these clinics or their treatments are approved by the FDA, and the only proof of their effectiveness is anecdotal, coming from selected customers.
Anyone with a chronic, progressive disease, such as COPD, will usually find themselves in a situation of desperation, eager to embrace any promises of a cure. I have been there, and it is a terrible situation.
Sadly, further research shows that institutions that are working on stem cell therapy for lungs unanimously agree that the successful regeneration of human lung tissue is likely decades away. Dr. Hatch, a British researcher, states that he may be able to announce success in about 20 years. Boston University states that stem cell treatment for lungs may be available for our grandchildren or great-grandchildren.
Even the Center for Regenerative Medicine at Wake Forest, which has successfully built working bladders and other of the simpler internal organs, states that we are likely 20 years away from creating a lung.
There have always been those who would separate us from our money with promises of cures of everything from cancer to male pattern baldness. Please beware.
Jim Nelson is a former Glenwood Springs resident who works with regional and national cardiovascular and lung organizations.
Read more:
Beware stem cell therapy for lung disease
